MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced that the U.S. Department of Agriculture has approved a license for Nobivac®Canine Flu Bivalent vaccine – the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8.
Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine | Merck Newsroom Home
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.